Abstract
Objectives
We aimed to evaluate the multi-slice computed tomography (MSCT) features of pancreatic neuroendocrine neoplasms (P-NENs) and analyse the correlation between the MSCT features and pathological classification of P-NENs.
Methods
Forty-one patients, preoperatively investigated by MSCT and subsequently operated on with a histological diagnosis of P-NENs, were included. Various MSCT features of the primary tumour, lymph node, and distant metastasis were analysed. The relationship between MSCT features and pathologic classification of P-NENs was analysed with univariate and multivariate models.
Results
Contrast-enhanced images showed significant differences among the three grades of tumours in the absolute enhancement (P = 0.013) and relative enhancement (P = 0.025) at the arterial phase. Univariate analysis revealed statistically significant differences among the tumours of different grades (based on World Health Organization [WHO] 2010 classification) in tumour size (P = 0.001), tumour contour (P < 0.001), cystic necrosis (P = 0.001), tumour boundary (P = 0.003), dilatation of the main pancreatic duct (P = 0.001), peripancreatic tissue or vascular invasion (P < 0.001), lymphadenopathy (P = 0.011), and distant metastasis (P = 0.012). Multivariate analysis suggested that only peripancreatic tissue or vascular invasion (HR 3.934, 95 % CI, 0.426–7.442, P = 0.028) was significantly associated with WHO 2010 pathological classification.
Conclusions
MSCT is helpful in evaluating the pathological classification of P-NENs.
Key Points
• P-NENs are potentially malignant, and classification of P-NENs carries important prognostic value.
• MSCT plays an important role in the diagnosis and staging of P-NENs.
• Correlations between classification of P-NENs and imaging findings have not been systematically evaluated.
• MSCT could predict P-NENs classification and may be a useful prognostication tool.
Similar content being viewed by others
References
Oberg K, Eriksson B (2005) Endocrine tumours of the pancreas. Best Pract Res Clin Gastroenterol 19:753–781
Metz DC, Jensen RT (2008) Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors. Gastroenterology 135:1469–1492
Nicholls AG (1902) Simple Adenoma of the Pancreas arising from an Island of langerhans. J Med Res 8:385–395
Wilder R, Allan F, Power M, Robertson H (1927) Carcinoma of the islands of the pancreas: hyperinsulinism and hypoglycemia. J Am Med Assoc 89:348–355
Casadei R, Ricci C, Pezzilli R et al (2009) Value of both WHO and TNM classification systems for patients with pancreatic endocrine tumors: results of a single-center series. World J Surg 33:2458–2463
Rindi G, Arnold R, Bosman F et al (2010) Nomenclature and classification of neuroendocrine neoplasms of the digestive system. In: Bosman F, Carneiro F, Hruban R, Theise N (eds) WHO classification of tumors of the digestive system. IARC Press, Lyon, pp 13–14
Zerbi A, Falconi M, Rindi G et al (2010) Clinicopathological features of pancreatic endocrine tumors: a prospective multicenter study in Italy of 297 sporadic cases. Am J Gastroenterol 105:1421–1429
Yao JC, Hassan M, Phan A et al (2008) One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol 26:3063–3072
Panzuto F, Boninsegna L, Fazio N et al (2011) Metastatic and locally advanced pancreatic endocrine carcinomas: analysis of factors associated with disease progression. J Clin Oncol 29:2372–2377
Rappeport ED, Hansen CP, Kjaer A, Knigge U (2006) Multidetector computed tomography and neuroendocrine pancreaticoduodenal tumors. Acta Radiol 47:248–256
Bettini R, Boninsegna L, Mantovani W et al (2008) Prognostic factors at diagnosis and value of WHO classification in a mono-institutional series of 180 non-functioning pancreatic endocrine tumours. Ann Oncol 19:903–908
Foti G, Boninsegna L, Falconi M, Mucelli RP (2013) Preoperative assessment of nonfunctioning pancreatic endocrine tumours: role of MDCT and MRI. Radiol Med 118:1082–1101
Bettini R, Partelli S, Boninsegna L et al (2011) Tumor size correlates with malignancy in nonfunctioning pancreatic endocrine tumor. Surgery 150:75–82
Gallotti A, Johnston RP, Bonaffini PA et al (2013) Incidental neuroendocrine tumors of the pancreas: MDCT findings and features of malignancy. AJR Am J Roentgenol 200:355–362
Buetow PC, Parrino TV, Buck JL et al (1995) Islet cell tumors of the pancreas: pathologic-imaging correlation among size, necrosis and cysts, calcification, malignant behavior, and functional status. AJR Am J Roentgenol 165:1175–1179
Lewis RB, Lattin GE Jr, Paal E (2010) Pancreatic endocrine tumors: radiologic-clinicopathologic correlation. Radiographics 30:1445–1464
Ekeblad S, Skogseid B, Dunder K, Oberg K, Eriksson B (2008) Prognostic factors and survival in 324 patients with pancreatic endocrine tumor treated at a single institution. Clin Cancer Res 14:7798–7803
Rodallec M, Vilgrain V, Couvelard A et al (2006) Endocrine pancreatic tumours and helical CT: contrast enhancement is correlated with microvascular density, histoprognostic factors and survival. Pancreatology 6:77–85
d’Assignies G, Couvelard A, Bahrami S et al (2009) Pancreatic endocrine tumors: tumor blood flow assessed with perfusion CT reflects angiogenesis and correlates with prognostic factors. Radiology 250:407–416
Couvelard A, O'Toole D, Turley H et al (2005) Microvascular density and hypoxia-inducible factor pathway in pancreatic endocrine tumours: negative correlation of microvascular density and VEGF expression with tumour progression. Br J Cancer 92:94–101
Marion-Audibert AM, Barel C, Gouysse G et al (2005) Low microvessel density is an unfavorable histoprognostic factor in pancreatic endocrine tumors. Gastroenterology 125:1094–1104
Acknowledgments
The scientific guarantors of this publication are Dr. Shi-Ting Feng and Dr. Zi-Ping Li. The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article. This study received funding from the following sources: National Natural Science Foundation of China (81000626), Zhujiang Scientific and Technological New Star Foundation (2012 J2200084), Natural Science Foundation of Guangdong Privince (S2013010016004) and Fundamental Research Funds for the Central Universities of China (10ykpy11). Lianxiong Yuan (expert in statistics, Sun Yat-Sen University) kindly provided statistical advice for this manuscript. Institutional Review Board approval was obtained, and written informed consent was waived by the Institutional Review Board. No study subjects or cohorts have been previously reported. Methodology: retrospective diagnostic or prognostic study, performed at one institution.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Yanji Luo and Zhi Dong contributed equally to this work.
Rights and permissions
About this article
Cite this article
Luo, Y., Dong, Z., Chen, J. et al. Pancreatic neuroendocrine tumours: correlation between MSCT features and pathological classification. Eur Radiol 24, 2945–2952 (2014). https://doi.org/10.1007/s00330-014-3317-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-014-3317-4